São Paulo’s Butantan Receives One Million Doses of Chinese Covid-19 Vaccine

It is the second shipment of the vaccine, which still needs approval from federal health regulator Anvisa before it can be used. 120,000 doses were received from China on November 19th.

RIO DE JANEIRO, BRAZIL - (Reuters) Brazil’s Butantan Institute biomedical center on Thursday, December 3rd, received 1 million doses of a Chinese vaccine developed by Sinovac Biotech that is undergoing late-stage testing by the institute in São Paulo state.

The consignment of CoronaVac vaccine, which will be packaged and labeled at Butantan’s facilities, arrived at São Paulo’s Guarulhos airport.

It is the second shipment of the vaccine to arrive in Brazil, after 120,000 doses landed from China on November 19th; it still needs approval from federal health regulator ANVISA before it can be used . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?